脂肪性肝炎-话题@MedSci

#脂肪性肝炎#

121篇内容 | 1366人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2194501, encodeId=69ad2194501e8, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a> <a href='/topic/show?id=a36b2541439' target=_blank style='color:#2F92EE;'>#代谢功能障碍#</a> <a href='/topic/show?id=ecc4153500b' target=_blank style='color:#2F92EE;'>#Resmetirom#</a>, objectTitle=Nature：对抗代谢功能障碍相关的脂肪性肝炎(MASH)：全球数百万患者治疗的新选择, objectType=article, longId=817647, objectId=6c3681e64798, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-writing-a-medical-recipe-P8LEKCP.jpg, objectUrl=/article/show_article.do?id=6c3681e64798, replyNumber=0, likeNumber=11, createdTime=2024-03-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6c3681e64798, moduleTitle=Nature：对抗代谢功能障碍相关的脂肪性肝炎(MASH)：全球数百万患者治疗的新选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c3681e64798)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1956131, encodeId=c9271956131e4, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=European Radiology：在接受NAC的乳腺癌患者中，测量这一影像学指标可预测化疗相关脂肪性肝炎！, objectType=article, longId=735944, objectId=edb5e359444e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edb5e359444e, replyNumber=0, likeNumber=43, createdTime=2023-06-28, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edb5e359444e, moduleTitle=European Radiology：在接受NAC的乳腺癌患者中，测量这一影像学指标可预测化疗相关脂肪性肝炎！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edb5e359444e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956133, encodeId=a986195613329, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=Radiology：超声衰减成像在非酒精性脂肪性肝炎诊断中的应用, objectType=article, longId=739482, objectId=7a25e394825a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a25e394825a, replyNumber=0, likeNumber=46, createdTime=2023-08-17, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a25e394825a, moduleTitle=Radiology：超声衰减成像在非酒精性脂肪性肝炎诊断中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a25e394825a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956130, encodeId=16821956130ec, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=Hepatology | 非酒精性脂肪性肝炎的潜在治疗新靶点被发现, objectType=article, longId=733353, objectId=f035e33353ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f035e33353ca, replyNumber=0, likeNumber=30, createdTime=2023-06-14, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f035e33353ca, moduleTitle=Hepatology | 非酒精性脂肪性肝炎的潜在治疗新靶点被发现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f035e33353ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956132, encodeId=ec2a1956132f4, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=非酒精性脂肪性肝炎的免疫细胞介导特征, objectType=article, longId=727254, objectId=0c1be272546c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c1be272546c, replyNumber=0, likeNumber=36, createdTime=2023-03-29, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c1be272546c, moduleTitle=非酒精性脂肪性肝炎的免疫细胞介导特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c1be272546c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956124, encodeId=19d71956124dc, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=Eur Heart J：复方丸预防心血管疾病，重点是非酒精性脂肪性肝炎, objectType=article, longId=294480, objectId=a62a294480a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a62a294480a6, replyNumber=0, likeNumber=26, createdTime=2022-03-24, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a62a294480a6, moduleTitle=Eur Heart J：复方丸预防心血管疾病，重点是非酒精性脂肪性肝炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a62a294480a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956123, encodeId=ac6d195612396, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=Hepatology：肝硬化消退与非酒精性脂肪性肝炎患者临床结局改善相关, objectType=article, longId=221278, objectId=e5522212e813, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5522212e813, replyNumber=0, likeNumber=31, createdTime=2022-06-25, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5522212e813, moduleTitle=Hepatology：肝硬化消退与非酒精性脂肪性肝炎患者临床结局改善相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5522212e813)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956129, encodeId=98ec19561293e, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=FDA授予辉瑞Ervogastat/Clesacostat用于非酒精性脂肪性肝炎 (NASH) 的快速通道资格, objectType=article, longId=728015, objectId=c099e2801596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c099e2801596, replyNumber=0, likeNumber=41, createdTime=2022-12-30, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c099e2801596, moduleTitle=FDA授予辉瑞Ervogastat/Clesacostat用于非酒精性脂肪性肝炎 (NASH) 的快速通道资格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c099e2801596)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956119, encodeId=2f071956119a3, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=Efruxifermin (EFX) 治疗非酒精性脂肪性肝炎 (NASH)，FDA授予其“快速通道资格”, objectType=article, longId=218971, objectId=bfc82189e193, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bfc82189e193, replyNumber=0, likeNumber=40, createdTime=2022-07-02, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bfc82189e193, moduleTitle=Efruxifermin (EFX) 治疗非酒精性脂肪性肝炎 (NASH)，FDA授予其“快速通道资格”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bfc82189e193)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956118, encodeId=0b8d195611853, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=Nat Med：Aramchol在非酒精性脂肪性肝炎患者中的应用：一项随机、双盲、安慰剂对照的2b期试验 , objectType=article, longId=218332, objectId=a64b21833225, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a64b21833225, replyNumber=0, likeNumber=61, createdTime=2022-01-14, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a64b21833225, moduleTitle=Nat Med：Aramchol在非酒精性脂肪性肝炎患者中的应用：一项随机、双盲、安慰剂对照的2b期试验 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a64b21833225)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956120, encodeId=d7941956120fd, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=Hepatology：灯盏花素减轻非酒精性脂肪性肝炎的机制研究, objectType=article, longId=219586, objectId=b585219586dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b585219586dd, replyNumber=0, likeNumber=33, createdTime=2022-02-12, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b585219586dd, moduleTitle=Hepatology：灯盏花素减轻非酒精性脂肪性肝炎的机制研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b585219586dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956116, encodeId=2b72195611606, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=Nat Commun：小檗碱治疗非酒精性脂肪性肝炎和2型糖尿病具有良好的耐受性, objectType=article, longId=217319, objectId=8c1321e31970, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c1321e31970, replyNumber=0, likeNumber=51, createdTime=2022-03-02, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c1321e31970, moduleTitle=Nat Commun：小檗碱治疗非酒精性脂肪性肝炎和2型糖尿病具有良好的耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c1321e31970)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956128, encodeId=83da195612826, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=Nature Communications：为何女性不易患非酒精性脂肪性肝炎？, objectType=article, longId=301269, objectId=c781301269a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c781301269a1, replyNumber=0, likeNumber=34, createdTime=2022-05-29, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c781301269a1, moduleTitle=Nature Communications：为何女性不易患非酒精性脂肪性肝炎？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c781301269a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956127, encodeId=ac62195612ecf, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=APT：胰高糖素样肽-1受体激动剂在非酒精性脂肪性肝炎、肥胖和糖尿病中的作用！, objectType=article, longId=300963, objectId=0b32300963be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b32300963be, replyNumber=0, likeNumber=40, createdTime=2022-07-19, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b32300963be, moduleTitle=APT：胰高糖素样肽-1受体激动剂在非酒精性脂肪性肝炎、肥胖和糖尿病中的作用！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b32300963be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956126, encodeId=a34019561268b, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=APT：胰高糖素样肽-1受体激动剂在非酒精性脂肪性肝炎、肥胖和糖尿病中的作用, objectType=article, longId=301055, objectId=3c31301055f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c31301055f6, replyNumber=0, likeNumber=24, createdTime=2022-05-16, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c31301055f6, moduleTitle=APT：胰高糖素样肽-1受体激动剂在非酒精性脂肪性肝炎、肥胖和糖尿病中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c31301055f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956125, encodeId=30c51956125a5, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=Clin Gastroenterology H: 体重变化与非酒精性脂肪性肝炎组织学特征和血液标志物变化的关联, objectType=article, longId=295541, objectId=638a29554100, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=638a29554100, replyNumber=0, likeNumber=35, createdTime=2023-01-25, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=638a29554100, moduleTitle=Clin Gastroenterology H: 体重变化与非酒精性脂肪性肝炎组织学特征和血液标志物变化的关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=638a29554100)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956112, encodeId=bf2c19561127e, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=Nat Med：Efruxifermin治疗非酒精性脂肪性肝炎的疗效和安全性分析, objectType=article, longId=214042, objectId=005e214042e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=005e214042e3, replyNumber=0, likeNumber=42, createdTime=2022-01-26, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=005e214042e3, moduleTitle=Nat Med：Efruxifermin治疗非酒精性脂肪性肝炎的疗效和安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=005e214042e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956114, encodeId=44b51956114b3, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=J Clincal Gastroenterology：肾功能衰竭与非酒精性脂肪性肝炎患者的死亡率增加有关, objectType=article, longId=214967, objectId=b6cc21496e09, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6cc21496e09, replyNumber=0, likeNumber=37, createdTime=2022-05-05, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6cc21496e09, moduleTitle=J Clincal Gastroenterology：肾功能衰竭与非酒精性脂肪性肝炎患者的死亡率增加有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6cc21496e09)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956122, encodeId=06ae1956122ad, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=J Hepatol：口服FXR激动剂EDP-305治疗非酒精性脂肪性肝炎的疗效, objectType=article, longId=220041, objectId=456022004188, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=456022004188, replyNumber=0, likeNumber=40, createdTime=2022-03-10, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=456022004188, moduleTitle=J Hepatol：口服FXR激动剂EDP-305治疗非酒精性脂肪性肝炎的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=456022004188)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956121, encodeId=94f11956121d7, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=AJG：他汀类药物对非酒精性脂肪性肝炎肝硬化患者的肝细胞癌具有化学预防作用, objectType=article, longId=219990, objectId=7da9219990b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7da9219990b5, replyNumber=0, likeNumber=24, createdTime=2021-12-15, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7da9219990b5, moduleTitle=AJG：他汀类药物对非酒精性脂肪性肝炎肝硬化患者的肝细胞癌具有化学预防作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7da9219990b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

脂肪性肝炎

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#脂肪性肝炎# #代谢功能障碍# #Resmetirom#

Nature：对抗代谢功能障碍相关的脂肪性肝炎(MASH)：全球数百万患者治疗的新选择

2024-03-21发表于上海

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

European Radiology：在接受NAC的乳腺癌患者中，测量这一影像学指标可预测化疗相关脂肪性肝炎！

2023-06-28

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

Radiology：超声衰减成像在非酒精性脂肪性肝炎诊断中的应用

2023-08-17

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

Hepatology | 非酒精性脂肪性肝炎的潜在治疗新靶点被发现

2023-06-14

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

非酒精性脂肪性肝炎的免疫细胞介导特征

2023-03-29

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

Eur Heart J：复方丸预防心血管疾病，重点是非酒精性脂肪性肝炎

2022-03-24

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

Hepatology：肝硬化消退与非酒精性脂肪性肝炎患者临床结局改善相关

2022-06-25

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

FDA授予辉瑞Ervogastat/Clesacostat用于非酒精性脂肪性肝炎 (NASH) 的快速通道资格

2022-12-30

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

Efruxifermin (EFX) 治疗非酒精性脂肪性肝炎 (NASH)，FDA授予其“快速通道资格”

2022-07-02

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

Nat Med：Aramchol在非酒精性脂肪性肝炎患者中的应用：一项随机、双盲、安慰剂对照的2b期试验

2022-01-14

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

Hepatology：灯盏花素减轻非酒精性脂肪性肝炎的机制研究

2022-02-12

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

Nat Commun：小檗碱治疗非酒精性脂肪性肝炎和2型糖尿病具有良好的耐受性

2022-03-02

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

Nature Communications：为何女性不易患非酒精性脂肪性肝炎？

2022-05-29

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

APT：胰高糖素样肽-1受体激动剂在非酒精性脂肪性肝炎、肥胖和糖尿病中的作用！

2022-07-19

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

APT：胰高糖素样肽-1受体激动剂在非酒精性脂肪性肝炎、肥胖和糖尿病中的作用

2022-05-16

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

Clin Gastroenterology H: 体重变化与非酒精性脂肪性肝炎组织学特征和血液标志物变化的关联

2023-01-25

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

Nat Med：Efruxifermin治疗非酒精性脂肪性肝炎的疗效和安全性分析

2022-01-26

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

J Clincal Gastroenterology：肾功能衰竭与非酒精性脂肪性肝炎患者的死亡率增加有关

2022-05-05

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

J Hepatol：口服FXR激动剂EDP-305治疗非酒精性脂肪性肝炎的疗效

2022-03-10

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

AJG：他汀类药物对非酒精性脂肪性肝炎肝硬化患者的肝细胞癌具有化学预防作用

2021-12-15

科室
- - 订阅+
  - 更多科室
工具
服务